Lg Group Photo transparent.png

The Summit Virtual

Fitness Challenge 2020

Events:
2020-10-28 (2).png

Click on image- Download pdf 

The Summit Virtual Fitness Challenge

starts with YOU!

 

Show your support

for the 10+ million worldwide struggling with Parkinson’s disease today.

Join us in taking a pledge to exercise for 21 days in support of those with Parkinson’s.

Anyone. Any way. Anywhere. 

 

Registration: $25.00

Registration begins: November 4, 2020 

Challenge dates: November 14 – December 6, 2020

 

Register TODAY!

Help find a Victory Over Parkinson’s.

Raise Funds. Raise Awareness.

Connect with

Fitbit, Garmin,

Apple Watch, Google Fit,

Misfit, Strava

or download IOS or Android apps

Track 

Your Progress

Anytime &

Anywhere !

"What are you doing...?"

Share a Video on FaceBook

Let the World know what you are doing to help Parkinson's

LOGO FB.png

Track Progress on Virtual Map!

Goal: 2,500 miles total miles by everyone registered​

Equivalent to length of Mississippi River 

Create your own icon and watch YOUR progress and standing.

 

 

 

Summit for Stem Cell Foundation is a 501(c)(3) charitable organization that is dependent on donations to support our programs. The proceeds from our will help support Summit’s programs:

 

  • Research Program: Support innovative evidence-based research looking at “old” questions with a new focus.

  • Patient Support Program:

    • a) Provide current & reliable information to patients.

    • b) Patient Financial assistance – For patients enrolled in FDA approved clinical trials in or affecting the field of regenerative medicine.

  • Educational Program: Dedicated to bridging the informational gap between evidence-based science and the patient & medical communities.

    • a) Accredited Continuing Medical Education (CME) courses for medical professionals with world-class leaders in regenerative medicine as presenters.

    • b) Reliable information empowering patients with the ability to separate stem cell hope from hype and to safely navigate stem cell therapies.

Proceeds: